The challenge isn’t just access to fertility benefits, it’s how those benefits are structured and delivered. Here are three emerging themes that can help employers better align cost, quality and experience.
Ideas floated by the Trump Administration and Democrats in Congress aim to expand access to fertility treatment as an essential health benefit. But an influx of patients could collide with an already-brittle system of 430,000 annual cycles, 5,000 embryologists, and long-overdue lab upgrades.
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
President Donald Trump recently announced an executive order on IVF. But it doesn't actually do much yet. Rather, it's asking for a list of recommendations to protect IVF access.
Future Family launched a nationwide IVF insurance product on Wednesday. If families don't achieve a live birth after two cycles of IVF, they can get their money back.
Gameto's $33 million Series B funding round was led by Two Sigma Ventures and RA Capital. The funding will help with the clinical development of its in vitro maturation product called Fertilo.
By investing in the value chain of IVF with the right AI solutions, investors can solve the access problem growing in the IVF space, help more people build their families, and achieve significant ROI.
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
AI bridges the gap of human error and maximizes the potential success rates of IVF. AI’s ability to analyze big data paves the way for improving IVF outcomes and the development of evidence-based parameters that establish a consistent standard of care.
By augmenting the embryologist in selecting the most viable embryo, there is potential for AI to help a patient conceive in one or two cycles, reducing the inherent cost of IVF therapy, and making the treatment more accessible to diverse populations that often don’t have ease of access to treatments today.
Through thoughtful consumer-centric design and application, these digital fertility solutions have the potential to smooth the path towards parenthood for countless couples and individuals around the world.
The lawsuit alleges that an Aetna policy discriminates against LGBTQ people by requiring them to pay thousands in out-of-pocket costs for fertility treatments before becoming eligible for coverage. Though Aetna has agreed to pay the costs incurred by the plaintiffs, the suit aims to strike down the policy as a whole.
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
Big name executives including former GE CEO Jeff Immelt, former Yahoo CEO Marissa Mayer, LinkedIn CEO Jeff Weiner and Levi’s CEO Chip Bergh also made personal investments in the company as part of the Series B round led by NEA.
The company uses machine learning-based analysis of clinical data to help fertility clinics provide personalized patient reports with success probabilities for potential IVF participants.
Aspect Ventures led the $10 million Series A round. BBG Ventures, LaunchCapital, iNovia, RiverPark Ventures, Ulu Ventures, Day One Ventures and Portfolia participated.
Goodbye Obamacare, hello maple-leaf onesies?
Modern Family actress Sofia Vergara is being sued by her unborn embryos. It's a bizarre case that highlights the challenging intersection of science and family law, all while the Trump government gears up for a pro-life renaissance.